330 people have bought this recently
Triohale Inhaler (1), a prescription drug, is manufactured in various forms such as Inhaler. Secondary and off-label uses of Triohale Inhaler (1) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Triohale Inhaler (1). The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Triohale Inhaler (1) as well, which are listed below. Normally, these side effects of Triohale Inhaler (1) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Triohale Inhaler (1) has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Triohale Inhaler (1)'s effects on the liver, heart and kidney, if any, have been listed below.
Triohale Inhaler (1) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema are examples of such conditions. Other conditions have been mentioned below in the Triohale Inhaler (1) contraindications section.
Additionally, Triohale Inhaler (1) may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Triohale Inhaler (1) is considered safe while driving, and is addictive.
Triohale Inhaler (1) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Triohale Inhaler (1) is used -
Severe
Moderate
Mild
Unknown
Is the use of Triohale Inhaler (1) safe for pregnant women?
Triohale can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Triohale Inhaler (1) safe during breastfeeding?
Triohale may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Triohale Inhaler (1) on the Kidneys?
Very few cases of side effects of Triohale on kidney have been reported.
What is the effect of Triohale Inhaler (1) on the Liver?
Triohale can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Triohale Inhaler (1) on the Heart?
You may experience side effects on your heart after taking Triohale. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Triohale Inhaler (1) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Triohale Inhaler (1) unless your doctor advises you to do so -
Is this Triohale Inhaler (1) habit forming or addictive?
Triohale Inhaler (1) does not cause addiction.
Interaction between Food and Triohale Inhaler (1)
Due to the absence of research, it is difficult to say how Triohale Inhaler (1) and food will interact.
Interaction between Alcohol and Triohale Inhaler (1)
Consumption of alcohol and Triohale Inhaler (1) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alvesco® (ciclesonide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1207
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Spiriva® HandiHaler® (tiotropium bromide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Braltus® (tiotropium bromide)
Download App
